Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03521245
Title Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer
Recruitment Unknown status
Gender female
Phase Phase I
Variant Requirements No
Sponsors Omicsway Corporation
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.